International Journal of Oncology

Papers
(The TQCC of International Journal of Oncology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
EDITORIAL The International Journal of Oncology: 30 years of progress (1992-2021)176
Histone lysine demethylase 3B regulates autophagy via transcriptional regulation of GABARAPL1 in acute myeloid leukemia cells103
[Retracted] Mst1 regulates non‑small cell lung cancer A549 cell apoptosis by inducing mitochondrial damage via ROCK1/F‑actin pathways80
[Corrigendum] SB‑T‑121205, a next‑generation taxane, enhances apoptosis and inhibits migration/invasion in MCF‑7/PTX cells68
[Retracted] miR‑486 suppresses the development of osteosarcoma by regulating PKC‑δ pathway57
[Retracted] MicroRNA‑488 inhibits proliferation, invasion and EMT in osteosarcoma cell lines by targeting aquaporin 350
Unleashing the power of urine‑based biomarkers in diagnosis, prognosis and monitoring of bladder cancer (Review)49
Traditional and emerging therapies for anaplastic large cell lymphoma (Review)45
PPM1G and its diagnostic, prognostic and therapeutic potential in HCC (Review)41
Epigenetic silencing of ZCCHC10 by the lncRNA SNHG1 promotes progression and venetoclax resistance of acute myeloid leukemia41
Nuclear miRNAs as transcriptional regulators in processes related to various cancers (Review)40
Sequestosome 1/p62: A multitasker in the regulation of malignant tumor aggression (Review)40
Targeting MUCL1 protein inhibits cell proliferation and EMT by deregulating β‑catenin and increases irinotecan sensitivity in colorectal cancer38
The EDN1/EDNRA/β‑arrestin axis promotes colorectal cancer progression by regulating STAT3 phosphorylation37
LncCCAT1 interaction protein PKM2 upregulates SREBP2 phosphorylation to promote osteosarcoma tumorigenesis by enhancing the Warburg effect and lipogenesis33
[Retracted] Zinc finger protein‑like 1 is a novel neuroendocrine biomarker for prostate cancer32
DNA methylation and breast cancer: A way forward (Review)32
Butyrate supplementation regulates expression of chromosome segregation 1‑like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer31
Effect of DPP4/CD26 expression on SARS‑CoV‑2 susceptibility, immune response, adenosine (derivatives m62A and CD) regulations on patients with cancer and healthy individuals29
[Corrigendum] The role of IGFBP‑5 in mediating the anti‑proliferation effect of tetrandrine in human colon cancer cells29
Aberrant alternative splicing in cancer: Splicing events and their regulatory mechanisms (Review)28
Myeloid‑derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review)28
Isoforms of the orphan nuclear receptor COUP‑TFII differentially modulate pancreatic cancer progression28
Treatment of patients with cancer using PD‑1/PD‑L1 antibodies: Adverse effects and management strategies (Review)27
Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review)26
Identification and characterization of slow‑cycling cells in Ewing sarcoma26
Long non‑coding RNA 01614 hyperactivates WNT/β‑catenin signaling to promote pancreatic cancer progression by suppressing GSK‑3β26
LINC00514 promotes lipogenesis and tumor progression in esophageal squamous cell carcinoma by sponging miR‑378a‑5p to enhance SPHK1 expression26
Recent advances in postoperative pulmonary rehabilitation of patients with non‑small cell lung cancer (Review)25
Ex vivo assessment of cancer drug sensitivity in epithelial ovarian cancer and its association with histopathological type, treatment history and clinical outcome25
FGFR‑related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review)24
Protein disulfide isomerase A1‑associated pathways in the development of stratified breast cancer therapies24
α‑hederin overcomes hypoxia‑mediated drug resistance in colorectal cancer by inhibiting the AKT/Bcl2 pathway24
Non‑coding RNA‑mediated epigenetic modification of ferroptosis in non‑small cell lung cancer (Review)23
Anti‑angiogenic effect of Bryopsis plumosa‑derived peptide via aquaporin 3 in non‑small cell lung cancer23
MYBBP1A‑mediated IGFBP4 promoter methylation promotes epithelial‑mesenchymal transition and metastasis through activation of NOTCH pathway in liver cancer22
Combined inhibition of IL‑6 and IL‑8 pathways suppresses ovarian cancer cell viability and migration and tumor growth22
Chromobox proteins in cancer: Multifaceted functions and strategies for modulation (Review)22
Targeting ncRNAs to overcome metabolic reprogramming‑mediated drug resistance in cancer (Review)21
MicroRNA in adenoid cystic carcinoma (Review)21
Effects of exosomes on tumor immunomodulation and their potential clinical applications (Review)21
Correlation of SARS‑CoV‑2 to cancer: Carcinogenic or anticancer? (Review)20
Inhibition of protein arginine methyltransferase 6 activates interferon signaling and induces the apoptosis of endometrial cancer cells via histone modification19
TIP60 governs the auto‑ubiquitination of UHRF1 through USP7 dissociation from the UHRF1/USP7 complex19
Human‑made electromagnetic fields: Ion forced‑oscillation and voltage‑gated ion channel dysfunction, oxidative stress and DNA damage (Review)19
Discovery of a potent cytotoxic agent that promotes G2/M phase cell cycle arrest and apoptosis in a malignant human pharyngeal squamous carcinoma cell line19
[Corrigendum] Cancer‑associated fibroblasts from invasive breast cancer have an attenuated capacity to secrete collagens19
HER2+ advanced gastric cancer: Current state and opportunities (Review)18
[Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer18
Beyond tumor‑associated macrophages involved in spheroid formation and dissemination: Novel insights for ovarian cancer therapy (Review)18
lncRNA SNHG22 sponges miR‑128‑3p to promote the progression of colorectal cancer by upregulating E2F318
Fucoxanthin suppresses pancreatic cancer progression by inducing bioenergetics metabolism crisis and promoting SLC31A1‑mediated sensitivity to DDP18
Biological functions of circRNA in regulating the hallmarks of gastrointestinal cancer (Review)18
Realgar‑induced KRAS mutation lung cancer cell death via KRAS/Raf/MAPK mediates ferroptosis18
Transposable elements and Piwi‑interacting RNAs in hemato‑oncology with a focus on myelodysplastic syndrome (Review)17
MicroRNA‑198 suppresses tumour growth and metastasis in oral squamous cell carcinoma by targeting CDK417
Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic (Review)16
YTHDF1 promotes the viability and self‑renewal of glioma stem cells by enhancing LINC00900 stability16
miR‑383 increases the cisplatin sensitivity of lung adenocarcinoma cells through inhibition of the RBM24‑mediated NF‑κB signaling pathway16
Targeting key RNA methylation enzymes to improve the outcome of colorectal cancer chemotherapy (Review)16
Heterogeneity of primary and metastatic CAFs: From differential treatment outcomes to treatment opportunities (Review)16
Role of miR‑181a‑5p in cancer (Review)16
Circadian clock as a possible control point in colorectal cancer progression (Review)16
Epigenetic modification regulates tumor progression and metastasis through EMT (Review)15
Tumor suppressive functions of hsa‑miR‑34a on cell cycle, migration and protective autophagy in bladder cancer15
Pan‑cancer analyses reveal the regulation and clinical outcome association of PCLAF in human tumors15
Modulation of PD‑L1 expression by standard therapy in head and neck cancer cell lines and exosomes15
Glioma‑neuronal interactions in tumor progression: Mechanism, therapeutic strategies and perspectives (Review)15
TRIM35 ubiquitination regulates the expression of PKM2 tetramer and dimer and affects the malignant behaviour of breast cancer by regulating the Warburg effect15
Epigenetic and epitranscriptomic role of lncRNA in carcinogenesis (Review)14
MELK predicts poor prognosis and promotes metastasis in esophageal squamous cell carcinoma via activating the NF‑κB pathway14
Immunotherapy for nasopharyngeal carcinoma: Current status and prospects (Review)14
Molecular mechanisms and targeted therapy for the metastasis of prostate cancer to the bones (Review)14
The ALK1‑Smad1/5‑ID1 pathway participates in tumour angiogenesis induced by low‑dose photodynamic therapy14
Recent progress of circular RNAs in different types of human cancer: Technological landscape, clinical opportunities and challenges (Review)14
A novel ferroptosis‑related gene signature for overall survival prediction and immune infiltration in patients with breast cancer14
The TLR7/8 agonist R848 optimizes host and tumor immunity to improve therapeutic efficacy in murine lung cancer14
Roles of voltage‑gated potassium channels in the maintenance of pancreatic cancer stem cells14
lncKRT16P6 promotes tongue squamous cell carcinoma progression by sponging miR‑3180 and regulating GATAD2A expression13
Establishment of patient‑derived lung tumorspheres and their response to internal irradiation by Auger electrons13
[Retracted] Feroniellin A‑induced autophagy causes apoptosis in multidrug‑resistant human A549 lung cancer cells13
Cinobufagin inhibits M2‑like tumor‑associated macrophage polarization to attenuate the invasion and migration of lung cancer cells13
Human cytomegalovirus infection enhances 5‑lipoxygenase and cycloxygenase‑2 expression in colorectal cancer13
Transmembrane serine protease 2 is a prognostic factor for lung adenocarcinoma13
Synergistic effects of the combined treatment of U251 and T98G glioma cells with an anti‑tubulin tetrahydrothieno[2,3‑c]pyridine derivative and a peptide nucleic acid targeting miR‑221‑3p13
CXCR4 blockade sensitizes osteosarcoma to doxorubicin by inducing autophagic cell death via PI3K‑Akt‑mTOR pathway inhibition13
The impact of radiation therapy on the TCR Vβ chain repertoire in patients with prostate cancer13
Novel insights on gut microbiota manipulation and immune checkpoint inhibition in cancer (Review)13
Synergism of a novel MCL‑1 downregulator, acriflavine, with navitoclax (ABT‑263) in triple‑negative breast cancer, lung adenocarcinoma and glioblastoma multiforme12
[Corrigendum] Wnt‑signaling and apoptosis after neoadjuvant short‑term radiotherapy for rectal cancer12
BST2 regulated by the transcription factor STAT1 can promote metastasis, invasion and proliferation of oral squamous cell carcinoma via the AKT/ERK1/2 signaling pathway12
FUT2 promotes the tumorigenicity and metastasis of colorectal cancer cells via the Wnt/β‑catenin pathway12
lncRNA HCP5 acts as a ceRNA to regulate EZH2 by sponging miR‑138‑5p in cutaneous squamous cell carcinoma12
[Corrigendum] METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma12
Role of the Wnt signaling pathway in the complex microenvironment of breast cancer and prospects for therapeutic potential (Review)12
[Corrigendum] Linc00961 inhibits the proliferation and invasion of skin melanoma by targeting the miR‑367/PTEN axis12
Role of Nectin‑4 protein in cancer (Review)12
Antagonism of the transient receptor potential melastatin‑2 channel leads to targeted antitumor effects in primary human malignant melanoma cells12
Effects of gut microbiome and obesity on the development, progression and prevention of cancer (Review)12
[Retracted] Interaction of YAP1 and mTOR promotes bladder cancer progression12
Targeting drug resistance in glioblastoma (Review)12
GSTO1 confers drug resistance in HCT‑116 colon cancer cells through an interaction with TNFαIP3/A2011
TDO2 modulates liver cancer cell migration and invasion via the Wnt5a pathway11
Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell lines11
Epigenetic modifications in acute myeloid leukemia: The emerging role of circular RNAs (Review)11
Knockdown of lncRNA MALAT1 induces pyroptosis by regulating the miR‑124/SIRT1 axis in cervical cancer cells11
Xenograft and organoid models in developing precision medicine for gastric cancer (Review)11
Daunorubicin induces GLI1‑dependent apoptosis in colorectal cancer cell lines11
Proliferating cell nuclear antigen directly interacts with androgen receptor and enhances androgen receptor‑mediated signaling11
Regulatory roles of miRNAs 16, 133a, and 223 on osteoclastic bone destruction caused by breast cancer metastasis11
Collagen type VI‑α1 and 2 repress the proliferation, migration and invasion of bladder cancer cells10
Visfatin inhibits colon cancer cell apoptosis and decreases chemosensitivity to 5‑FU by promoting the SDF‑1/CXCR4/Akt axis10
Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors10
Circular RNAs in osteosarcoma: An update of recent studies (Review)10
NQO1 drives glioblastoma cell aggressiveness through EMT induction via the PI3K/Akt/mTOR/Snail pathway10
Genome‑wide DNA hypomethylation drives a more invasive pancreatic cancer phenotype and has predictive occult distant metastasis and prognosis potential10
Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma10
ZNF740 facilitates the malignant progression of hepatocellular carcinoma via the METTL3/HIF‑1A signaling axis10
Roles of salt‑inducible kinases in cancer (Review)10
Advances in immune therapies for the treatment of microsatellite instability‑high/deficient mismatch repair metastatic colorectal cancer (Review)10
[Corrigendum] Macrophage‑secreted IL‑8 induces epithelial‑mesen­chymal transition in hepatocellular carcinoma cells by activating the JAK2/STAT3/Snail pathway10
Cx32 promotes autophagy and produces resistance to SN‑induced apoptosis via activation of AMPK signalling in cervical cancer10
Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review)10
Chimeric HDAC and the cytoskeleton inhibitor broxbam as a novel therapeutic strategy for liver cancer10
Activated KRAS reprograms neural progenitor cells to glioma stem cell‑like phenotype10
[Retracted] Slug contributes to cancer progression by direct regulation of ERα signaling pathway10
Investigating the molecular mechanisms of microRNA‑409‑3p in tumor progression: Towards targeted therapeutics (Review)10
Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling10
Endocrine nuclear receptors and long non‑coding RNAs reciprocal regulation in cancer (Review)9
Tumor‑associated macrophages activated in the tumor environment of hepatocellular carcinoma: Characterization and treatment (Review)9
Epigenetic modifications: Critical participants of the PD‑L1 regulatory mechanism in solid tumors (Review)9
lncRNA NEAT1 facilitates the progression of colorectal cancer via the KDM5A/Cul4A and Wnt signaling pathway9
Aptamer‑based therapy for targeting key mediators of cancer metastasis (Review)9
lncRNA cytoskeleton regulator reduces non‑small cell lung cancer radiosensitivity by downregulating miRNA‑206 and activating prothymosin α9
Macrophage migration inhibitory factor in the pathogenesis of leukemia (Review)9
Tumour follower cells: A novel driver of leader cells in collective invasion (Review)9
Potential of the tumor‑derived extracellular vesicles carrying the miR‑125b‑5p target TNFAIP3 in reducing the sensitivity of diffuse large B cell lymphoma to rituximab9
0.11223292350769